Garrett Winslow (LLM’05) promoted to General Counsel of Spring Bank
Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced the appointment of Kevin Leach, PhD, DABT, as vice president, nonclinical and translational research, a newly created role, and the promotion of Garrett Winslow (LLM in Taxation’05) to the position of general counsel.